Earth Science Tech Launches MyOnlineConsultation Platform Through MOCTeledoc Partnership
March 24th, 2026 1:41 PM
By: Newsworthy Staff
Earth Science Tech has launched its MyOnlineConsultation.com telehealth platform through MOCTeledoc, creating a new revenue stream by integrating its prescriber network with compounding pharmacies while achieving cash-flow-positive status during beta testing.

Earth Science Tech, Inc. has officially launched its MyOnlineConsultation.com platform through MOCTeledoc LLC, a fully integrated doctor network that provides technology and clinical staffing solutions to digital health companies. The platform emerged from a successful beta phase that achieved cash-flow-positive status, demonstrating early financial viability. This development represents a strategic expansion for ETST as it positions MOCTeledoc as a new revenue stream alongside divisions that generated $25.9 million for the nine months ended December 31, 2025.
The MyOnlineConsultation platform supports ETST's vertically integrated healthcare ecosystem by connecting its prescriber network with compounding pharmacies, including RxCompound and Mister Meds. The platform offers turnkey telehealth technology, clinical staffing, and integrated fulfillment services, creating a comprehensive digital health solution. This integration allows patients to access personalized care through telemedicine connectivity while ensuring medication fulfillment through ETST's pharmacy operations. The company's existing healthcare infrastructure, including Peaks Curative, DOConsultation.com, and Las Villas Health Care, provides additional clinical support for the platform's operations.
Beyond its healthcare operations, ETST manages Avenvi, its real estate and asset management arm, and MagneChef, a direct-to-consumer brand leveraging proprietary intellectual property for innovative kitchen products. The company also maintains a commitment to social responsibility through the Earth Science Foundation, a non-profit organization dedicated to assisting patients with prescription costs. The latest news and updates relating to ETST are available in the company's newsroom at https://ibn.fm/ETST.
The launch announcement was distributed through BioMedWire, a specialized communications platform focused on developments in biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is one of more than 75 brands within the Dynamic Brand Portfolio at IBN that delivers various communication solutions, including access to wire distribution networks, article syndication to over 5,000 outlets, enhanced press release services, social media distribution, and tailored corporate communications. For more information about BioMedWire's services, visit https://www.BioMedWire.com. Full terms of use and disclaimers applicable to all content provided by BioMedWire are available at https://www.BioMedWire.com/Disclaimer.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
